Erika Johnson - Biotage AB CFO

BITGF Stock  USD 16.87  0.00  0.00%   

CFO

Ms. Erika Soderberg Johnson was Chief Financial Officer at Biotage AB since January 2012. Prior to this, she held a corresponding position at Karo Bio. She is Member of the Board of Saab AB and Qliro Group AB. She holds a MS in Business Administration degree from Handelshogskolan i Stockholm. since 2012.
Age 48
Tenure 12 years
Phone46 18 56 59 00
Webhttps://www.biotage.com

Biotage AB Management Efficiency

The company has return on total asset (ROA) of 0.109 % which means that it generated a profit of $0.109 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1785 %, meaning that it generated $0.1785 on every $100 dollars invested by stockholders. Biotage AB's management efficiency ratios could be used to measure how well Biotage AB manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 150 M in total debt with debt to equity ratio (D/E) of 0.16, which may suggest the company is not taking enough advantage from borrowing. Biotage AB has a current ratio of 2.38, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Biotage AB until it has trouble settling it off, either with new capital or with free cash flow. So, Biotage AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotage AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotage to invest in growth at high rates of return. When we think about Biotage AB's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

CFO Age

Jeremy BarnumJPMorgan Chase Co
51
Gunnar WiedenfelsProSiebenSat1 Media AG
39
Rahul GhaiGE Aerospace
52
Jan KemperProSiebenSat1 Media AG
35
Francis ShammoVerizon Communications
54
Ralf GierigProSiebenSat1 Media AG
58
Jeffrey BornsteinGE Aerospace
50
Biotage AB provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. Biotage AB was founded in 1969 and is headquartered in Uppsala, Sweden. Biotage Ab is traded on OTC Exchange in the United States. Biotage AB [BITGF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Biotage AB Leadership Team

Elected by the shareholders, the Biotage AB's board of directors comprises two types of representatives: Biotage AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotage. The board's role is to monitor Biotage AB's management team and ensure that shareholders' interests are well served. Biotage AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotage AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Karolina Lawitz, Member of the Board of Directors
NilsOlof Bjork, Director
Love Amcoff, Director, Employee Representative
Thomas Eklund, Member of the Board of Directors
Rikke Rytter, Vice President Global Marketing
Mark Bradley, Director
Ove Mattsson, Chairman of the Board of Directors
Cecilia Hallner, Global Human Resources Director
Malin Albertsson, Director, Employee Representative
Erika Johnson, CFO
Petra Duprez, Chief Officer
Jonas Stahlberg, Chief Auditor
Raffaella Bombarda, EVP Marketing
Yvonne Martensson, Director
Steve Jordan, Chief Scientific Officer
Anders Wikstrom, Vice President - Operations
Lars Backman, Vice President of Corporate Development
Anders Walldov, Member of the Board of Directors
Scott Carr, Pres Americas
Tomas Blomquist, CEO Pres
Peter Ehrenheim, Member of the Board of Directors
Torben Joergensen, President and CEO
Maja Nilsson, Chief Officer
CS BSc, Ex Operations
Paul Belton, Vice President - Business Development
JonSverre Schanche, Chief Officer
Olof Nord, Exec Devel
Lars LLB, Chief Officer
Annika Gardlund, Director, Employee Representative

Biotage Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Biotage AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Biotage AB

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotage AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotage AB will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biotage OTC Stock

  0.74GOOG Alphabet Class C Aggressive PushPairCorr
  0.64AMZN Amazon Inc Earnings Call This WeekPairCorr

Moving against Biotage OTC Stock

  0.83MCD McDonalds Earnings Call This WeekPairCorr
  0.74JNJ Johnson Johnson Aggressive PushPairCorr
  0.74BA Boeing Financial Report 24th of July 2024 PairCorr
  0.71INTC Intel Earnings Call TodayPairCorr
  0.64AAPL Apple Inc Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Biotage AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotage AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotage AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotage AB to buy it.
The correlation of Biotage AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotage AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotage AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotage AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotage AB. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Biotage AB information on this page should be used as a complementary analysis to other Biotage AB's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Biotage OTC Stock analysis

When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
CEOs Directory
Screen CEOs from public companies around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Please note, there is a significant difference between Biotage AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotage AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotage AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.